CCNE1 AMPLIFICATION
Clinical trials for CCNE1 AMPLIFICATION explained in plain language.
Never miss a new study
Get alerted when new CCNE1 AMPLIFICATION trials appear
Sign up with your email to follow new studies for CCNE1 AMPLIFICATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called BLU-222 in people with advanced solid tumors that had stopped responding to standard treatments. The goal was to find a safe dose and see if it could shrink tumors. The trial was stopped early, so results are limited.
Matched conditions: CCNE1 AMPLIFICATION
Phase: PHASE1 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated May 26, 2026 06:00 UTC
-
Experimental cancer pill tested in 23 patients, study halted early
Disease control TerminatedThis early-stage study tested an experimental oral drug called NKT3447 in 23 adults with advanced solid tumors that had stopped responding to standard treatments. The goal was to check safety and find the right dose. The study was terminated early, so results are limited.
Matched conditions: CCNE1 AMPLIFICATION
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 05:56 UTC